Insulin lispro pens recalled for temperature exposure during distribution
Cardinal Health is recalling Humalog KwikPen insulin lispro pens distributed in New Mexico due to exposure to improper temperatures caused by inclement weather.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall. The severity rubric specifies that FDA Class I recalls receive a minimum score of 4, indicating a serious condition with potential for adverse health consequences.
Plain-English summary
Cardinal Health Inc. is recalling Humalog KwikPen insulin lispro injection, U-100, in prefilled pens with Box NDC 0002-8799-59. The recall affects pens distributed in New Mexico.
According to the recall notice, the products were exposed to temperatures outside their labeled storage conditions due to inclement weather during distribution.
Patients who have received affected pens should contact their healthcare provider to determine if the product should be used, and may contact Cardinal Health for further information regarding the recall.
The recalled product
- Product
- HUMALOG (INSULIN LISPRO)
- Brand
- HUMALOG
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Insulin / Injectable
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Unknown
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 3 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · HUMALOG
- HighEli Lilly Recalls Humalog Sterile Diluent Due to Manufacturing Deviations
FDA (Drugs) · 2024-04-24
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · temperature abuse
See all →- SevereKayem Foods Recalls Ready-to-Eat Meat and Poultry Due to Temperature Abuse
USDA FSIS · 2026-10-17
- ModerateZoladex Goserelin Implant Recalled Due to Temperature Abuse
FDA (Drugs) · 2026-10-07
- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
Similar recalls
- ModerateSanofi Recalls Admelog Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2018-07-18
- SevereNovo Nordisk Recalls Fiasp Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- ModerateCardinal Health Recalls EpiPen Auto-Injectors Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- SevereNovo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- ModerateCardinal Health Recalls Eszopiclone Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- CriticalNovo Nordisk Recalls Levemir Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21